SCHEMBL7980722

SCHEMBL7980722

C=CCCCOc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
KCNA3 P22001 1/20 0.62
TAAR1 Q96RJ0 1/20 0.50
RECQL P46063 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
DRD3 P35462 1/20 0.50
THRB P10828 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11323091 0.94 KCNA3 (0.67) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
SCHEMBL29565879 0.92 LTA4H (0.61) ALDH1A1L3MBTL1KCNA3HDAC1HDAC2
SCHEMBL31281844 0.92 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
SCHEMBL5053411 0.92 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
SCHEMBL18936005 0.92 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
SCHEMBL9684375 0.92 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
SCHEMBL7587977 0.92 KCNA3 (0.64) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
Allylanisole SCHEMBL4737421 0.89 KCNA3 (0.58) ALDH1A1L3MBTL1KCNA3TAAR1RECQL
SCHEMBL13420978 0.88 ALDH1A1 (0.60) ALDH1A1L3MBTL1KCNA3HDAC3HDAC4
SCHEMBL17138189 0.85 ALDH1A1 (0.51) ALDH1A1L3MBTL1KCNA3KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688743-A1 INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY University of Virginia Patent Foundation (US) 2026-02-11 EP disclosed
WO-2024206153-A1 INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-10-03 WO disclosed
CN-114805069-B Method for synthesizing alpha difluoro ester derivative from terminal olefin 天津科技大学 2023-09-29 CN disclosed
EP-3178323-B1 NOXIOUS ARTHROPOD CONTROL AGENT CONTAINING AMIDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2021-06-23 EP disclosed
CN-107903349-A Functional rare earth EP rubbers and preparation method thereof 大连理工大学 2018-04-13 CN disclosed
US-9854803-B2 Noxious arthropod control agent containing amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-02 US disclosed
US-20170215424-A1 NOXIOUS ARTHROPOD CONTROL AGENT CONTAINING AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-08-03 US disclosed
EP-3178323-A1 NOXIOUS ARTHROPOD CONTROL AGENT CONTAINING AMIDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2017-06-14 EP disclosed
US-6284868-B1 AT LEAST ONE 1-ALKENE THAT IS AN ARYL DERIVATIVE SUBSTITUTED WITH AT LEAST ONE TERMINAL ALLYL AND/OR HOMOALLYL MOIETY AND CONTAINING ONE OR MORE POLAR GROUPS; GROUP VIII METAL COMPLEX CATALYST BASF AKTIENGESELLSCHAFT (DE) 2001-09-04 US disclosed
EP-0991696-A1 FUNCTIONALISED CARBON MONOXIDE COPOLYMERS BASF AKTIENGESELLSCHAFT (DE) 2000-04-12 EP disclosed
WO-1999000443-A1 FUNCTIONALISED CARBON MONOXIDE COPOLYMERS BASF AKTIENGESELLSCHAFT (DE) 1999-01-07 WO disclosed
US-4450149-A REASCTING AN ORGANIC BORANE WITH A RADIOACTIVE HALOMONOCHLORIDE AND A MILD OXIDIZER; RADIOLOGY RESEARCH CORPORATION (US) 1984-05-22 US disclosed
EP-0028161-A1 Fluorinated phenolic polymer and process for its preparation E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-05-06 EP disclosed
US-4260552-A INSECTICIDES, HERBICIDES UNIROYAL, INC. (US) 1981-04-07 US disclosed
US-4160846-A Method for controlling insects with tetrasubstituted organotin compounds UNIROYAL, INC. (US) 1979-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170215424-A1 NOXIOUS ARTHROPOD CONTROL AGENT CONTAINING AMIDE COMPOUND TRPA1, OPRM1, OPRL1 ALDH1A1 2079/4885L3MBTL1 12/4885KCNA3 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.